{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T15:56:32Z","timestamp":1786982192181,"version":"build-2736575974"},"reference-count":61,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2024,4,2]],"date-time":"2024-04-02T00:00:00Z","timestamp":1712016000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,4,2]],"date-time":"2024-04-02T00:00:00Z","timestamp":1712016000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Endocrine"],"DOI":"10.1007\/s12020-024-03804-5","type":"journal-article","created":{"date-parts":[[2024,4,2]],"date-time":"2024-04-02T05:02:21Z","timestamp":1712034141000},"page":"883-893","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Role of bisphosphonates in hypertrophic osteoarthropathy: a systematic review"],"prefix":"10.1007","volume":"85","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2429-3595","authenticated-orcid":false,"given":"Rajan","family":"Palui","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5867-5073","authenticated-orcid":false,"given":"Kalyani","family":"Sridharan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jayaprakash","family":"Sahoo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Varun","family":"Suryadevara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sadishkumar","family":"Kamalanathan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dukhabandhu","family":"Naik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dhanapathi","family":"Halanaik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harsh","family":"Durgia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henith","family":"Raj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,4,2]]},"reference":[{"key":"3804_CR1","volume":"34","author":"M Mart\u00ednez-Lav\u00edn","year":"2020","unstructured":"M. Mart\u00ednez-Lav\u00edn, Hypertrophic osteoarthropathy. Best. Pr. Res Clin. Rheumatol. 34, 101507 (2020)","journal-title":"Best. Pr. Res Clin. Rheumatol."},{"key":"3804_CR2","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/j.berh.2011.10.019","volume":"25","author":"M Martinez-Lavin","year":"2011","unstructured":"M. Martinez-Lavin, Miscellaneous non-inflammatory musculoskeletal conditions. Pachydermoperiostosis. Best. Pr. Res Clin. Rheumatol. 25, 727\u2013734 (2011)","journal-title":"Best. Pr. Res Clin. Rheumatol."},{"key":"3804_CR3","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1038\/ng.153","volume":"40","author":"S Uppal","year":"2008","unstructured":"S. Uppal, C.P. Diggle, I.M. Carr, C.W.G. Fishwick, M. Ahmed, G.H. Ibrahim et al. Mutations in 15-hydroxyprostaglandin dehydrogenase cause primary hypertrophic osteoarthropathy. Nat. Genet 40, 789\u2013793 (2008)","journal-title":"Nat. Genet"},{"key":"3804_CR4","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.ajhg.2011.11.019","volume":"90","author":"Z Zhang","year":"2012","unstructured":"Z. Zhang, W. Xia, J. He, Z. Zhang, Y. Ke, H. Yue et al. Exome sequencing identifies SLCO2A1 mutations as a cause of primary hypertrophic osteoarthropathy. Am. J. Hum. Genet 90, 125\u2013132 (2012)","journal-title":"Am. J. Hum. Genet"},{"key":"3804_CR5","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1097\/MCD.0000000000000324","volume":"29","author":"P Radhakrishnan","year":"2020","unstructured":"P. Radhakrishnan, P. Jacob, S.S. Nayak, K. Gowrishankar, J. Prakash Soni, A. Shukla et al. Digital clubbing as the predominant manifestation of hypertrophic osteoarthropathy caused by pathogenic variants in HPGD in three Indian families. Clin. Dysmorphol. 29, 123\u2013126 (2020)","journal-title":"Clin. Dysmorphol."},{"key":"3804_CR6","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1111\/j.1399-0004.2005.00533.x","volume":"68","author":"M Castori","year":"2005","unstructured":"M. Castori, L. Sinibaldi, R. Mingarelli, R.S. Lachman, D.L. Rimoin, B. Dallapiccola, Pachydermoperiostosis: an update. Clin. Genet 68, 477\u2013486 (2005)","journal-title":"Clin. Genet"},{"key":"3804_CR7","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/0049-0172(85)90045-9","volume":"14","author":"CJ Pineda","year":"1985","unstructured":"C.J. Pineda, J. Guerra, M.H. Weisman, D. Resnick, M. Martinez-Lavin, The skeletal manifestations of clubbing: a study in patients with cyanotic congenital heart disease and hypertrophic osteoarthropathy. Semin Arthritis Rheum. 14, 263\u2013273 (1985)","journal-title":"Semin Arthritis Rheum."},{"key":"3804_CR8","doi-asserted-by":"crossref","first-page":"2079","DOI":"10.3892\/ol.2014.2022","volume":"7","author":"X Qian","year":"2014","unstructured":"X. Qian, J. Qin, Hypertrophic pulmonary osteoarthropathy with primary lung cancer. Oncol. Lett. 7, 2079\u20132082 (2014)","journal-title":"Oncol. Lett."},{"key":"3804_CR9","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1002\/art.41014","volume":"71","author":"E Clarke","year":"2019","unstructured":"E. Clarke, R. Bright-Thomas, Hypertrophic osteoarthropathy in cystic fibrosis. Arthritis Rheumatol. 71, 1633 (2019)","journal-title":"Arthritis Rheumatol."},{"key":"3804_CR10","first-page":"57","volume":"18","author":"LH Silveira","year":"2000","unstructured":"L.H. Silveira, M. Mart\u00ednez-Lav\u00edn, C. Pineda, M.C. Fonseca, C. Navarro, A. Nava, Vascular endothelial growth factor and hypertrophic osteoarthropathy. Clin. Exp. Rheumatol. 18, 57\u201362 (2000)","journal-title":"Clin. Exp. Rheumatol."},{"key":"3804_CR11","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1002\/path.1565","volume":"203","author":"S Atkinson","year":"2004","unstructured":"S. Atkinson, S.B. Fox, Vascular endothelial growth factor (VEGF)-A and platelet-derived growth factor (PDGF) play a central role in the pathogenesis of digital clubbing. J. Pathol. 203, 721\u2013728 (2004)","journal-title":"J. Pathol."},{"key":"3804_CR12","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1007\/s10067-010-1563-7","volume":"30","author":"S Nguyen","year":"2011","unstructured":"S. Nguyen, M. Hojjati, Review of current therapies for secondary hypertrophic pulmonary osteoarthropathy. Clin. Rheumatol. 30, 7\u201313 (2011)","journal-title":"Clin. Rheumatol."},{"key":"3804_CR13","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1111\/j.1445-5994.1997.tb01983.x","volume":"27","author":"D Speden","year":"1997","unstructured":"D. Speden, F. Nicklason, H. Francis, J. Ward, The use of pamidronate in hypertrophic pulmonary osteoarthropathy (HPOA). Aust. N. Z. J. Med. 27, 307\u2013310 (1997)","journal-title":"Aust. N. Z. J. Med."},{"key":"3804_CR14","first-page":"340","volume":"54","author":"A Bhansali","year":"2006","unstructured":"A. Bhansali, R. Singh, M. Sriraam, S. Bhadada, Pachydermoperiostitis and bisphosphonates. J. Assoc. Physicians India 54, 340 (2006)","journal-title":"J. Assoc. Physicians India"},{"key":"3804_CR15","first-page":"87","volume":"67","author":"RK Jagdish","year":"2019","unstructured":"R.K. Jagdish, M.K. Bhatnagar, A. Malhotra, R. Aggarwal, N. Shailly, Bisphosphonates use in pachydermoperiostosis. J. Assoc. Physicians India 67, 87\u201390 (2019)","journal-title":"J. Assoc. Physicians India"},{"key":"3804_CR16","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1097\/RHU.0000000000000289","volume":"21","author":"I Tachibana","year":"2015","unstructured":"I. Tachibana, D. Gehi, C.D. Rubin, Treatment of hypertrophic osteoarthropathy with underlying pulmonary adenocarcinoma using zoledronic acid. J. Clin. Rheumatol. 21, 333\u2013334 (2015)","journal-title":"J. Clin. Rheumatol."},{"key":"3804_CR17","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.semarthrit.2011.01.007","volume":"41","author":"BA Jayakar","year":"2011","unstructured":"B.A. Jayakar, A.G. Abelson, Q. Yao, Treatment of hypertrophic osteoarthropathy with zoledronic acid: case report and review of the literature. Semin Arthritis Rheum. 41, 291\u2013296 (2011)","journal-title":"Semin Arthritis Rheum."},{"key":"3804_CR18","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1097\/JTO.0b013e3181952915","volume":"4","author":"O Mauricio","year":"2009","unstructured":"O. Mauricio, L. Francis, U. Athar, C. Shah, M. Chaudhary, A. Gajra, Hypertrophic osteoarthropathy masquerading as lower extremity cellulitis and response to bisphosphonates. J. Thorac. Oncol. 4, 260\u2013262 (2009)","journal-title":"J. Thorac. Oncol."},{"key":"3804_CR19","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/j.semarthrit.2008.07.001","volume":"38","author":"Q Yao","year":"2009","unstructured":"Q. Yao, R.D. Altman, E. Brahn, Periostitis and hypertrophic pulmonary osteoarthropathy: report of 2 cases and review of the literature. Semin Arthritis Rheum. 38, 458\u2013466 (2009)","journal-title":"Semin Arthritis Rheum."},{"key":"3804_CR20","doi-asserted-by":"crossref","first-page":"e0179248","DOI":"10.1371\/journal.pone.0179248","volume":"12","author":"SY Gao","year":"2017","unstructured":"S. Y. Gao, G. S. Zheng, L. Wang, Y. J. Liang, S. E. Zhang, X. M. Lao et al. Zoledronate suppressed angiogenesis and osteogenesis by inhibiting osteoclasts formation and secretion of PDGF-BB. PloS ONE 12, e0179248 (2017)","journal-title":"PloS ONE"},{"key":"3804_CR21","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.cyto.2014.10.025","volume":"71","author":"S Ishtiaq","year":"2015","unstructured":"S. Ishtiaq, S. Edwards, A. Sankaralingam, Ba.J. Evans, C. Elford, M.L. Frost et al. The effect of nitrogen containing bisphosphonates, zoledronate and alendronate, on the production of pro-angiogenic factors by osteoblastic cells. Cytokine 71, 154\u2013160 (2015)","journal-title":"Cytokine"},{"key":"3804_CR22","doi-asserted-by":"crossref","first-page":"959","DOI":"10.3899\/jrheum.101077","volume":"38","author":"XF Sun","year":"2011","unstructured":"X. F. Sun, Q. J. Wu, Y. L. Bi, Y. Hou, M. T. Li, W. Zhang et al. Primary hypertrophic osteoarthropathy with gastric hypertrophy. J. Rheumatol. 38, 959\u2013960 (2011)","journal-title":"J. Rheumatol."},{"key":"3804_CR23","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1097\/RHU.0b013e3181e04d80","volume":"16","author":"S Narayanan","year":"2010","unstructured":"S. Narayanan, V.M.S. Mohamed Gani, V. Sundararaju, Primary hypertrophic osteoarthropathy with hypertrophic gastropathy. J. Clin. Rheumatol. 16, 190\u2013192 (2010)","journal-title":"J. Clin. Rheumatol."},{"key":"3804_CR24","doi-asserted-by":"crossref","unstructured":"Palui R., Sridharan K., Sahoo J., Kamalanathan S., Naik D., Halanaik D., et al. Role of bisphosphonates in hypertrophic osteoarthropathy: a systematic review. (2023); Available from: https:\/\/www.crd.york.ac.uk\/prospero\/display_record.php?ID=CRD42022343786","DOI":"10.1007\/s12020-024-03804-5"},{"key":"3804_CR25","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1136\/bmjebm-2017-110853","volume":"23","author":"MH Murad","year":"2018","unstructured":"M.H. Murad, S. Sultan, S. Haffar, F. Bazerbachi, Methodological quality and synthesis of case series and case reports. BMJ Evid. Based Med. 23, 60\u201363 (2018)","journal-title":"BMJ Evid. Based Med."},{"key":"3804_CR26","doi-asserted-by":"crossref","unstructured":"M. Gupta, S.S. Lehl, R. Singh, A. Sachdev, Touraine-Solente-Gole\u2019 syndrome. BMJ Case Rep. (2011).","DOI":"10.1136\/bcr.08.2011.4605"},{"key":"3804_CR27","first-page":"939","volume":"26","author":"MF Ahmmed","year":"2017","unstructured":"M.F. Ahmmed, M.N. Shazzad, S. Ferdous, A.K. Azad, S.A. Haq, Polyarthritis is a rare manifestation of pachydermoperiostosis: a case report. Mymensingh Med. J. 26, 939\u2013943 (2017)","journal-title":"Mymensingh Med. J."},{"key":"3804_CR28","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.reuma.2009.01.007","volume":"5","author":"N G\u00f3mez Rodr\u00edguez","year":"2009","unstructured":"N. G\u00f3mez Rodr\u00edguez, J. Ib\u00e1\u00f1ez Ru\u00e1n, M. Gonz\u00e1lez P\u00e9rez, [Primary hypertrophic osteoarthropathy (pachydermoperiostosis). Report of two familial cases and literature review. Reumatol. Clin. 5, 259\u2013263 (2009).","journal-title":"Reumatol. Clin."},{"key":"3804_CR29","doi-asserted-by":"crossref","first-page":"330","DOI":"10.3109\/s10165-007-0585-8","volume":"17","author":"H Jojima","year":"2007","unstructured":"H. Jojima, K. Kinoshita, M. Naito, A case of pachydermoperiostosis treated by oral administration of a bisphosphonate and arthroscopic synovectomy. Mod. Rheumatol. 17, 330\u2013332 (2007)","journal-title":"Mod. Rheumatol."},{"key":"3804_CR30","doi-asserted-by":"crossref","first-page":"938","DOI":"10.4103\/0301-4738.198865","volume":"64","author":"B Mukherjee","year":"2016","unstructured":"B. Mukherjee, M.S. Alam, A rare case of pachydermoperiostosis associated with blepharoptosis and floppy eyelids. Indian J. Ophthalmol. 64, 938\u2013940 (2016)","journal-title":"Indian J. Ophthalmol."},{"key":"3804_CR31","first-page":"81","volume":"43","author":"M Mobini","year":"2018","unstructured":"M. Mobini, O. Akha, H. Fakheri, H. Majidi, S. Fattahi, Pachydermoperiostosis in a patient with Crohn\u2019s disease: treatment and literature review. Iran. J. Med Sci. 43, 81\u201385 (2018)","journal-title":"Iran. J. Med Sci."},{"key":"3804_CR32","first-page":"2418","volume":"27","author":"MH Guyot-Drouot","year":"2000","unstructured":"M.H. Guyot-Drouot, E. Solau-Gervais, B. Cortet, X. Deprez, P. Chastanet, A. Cotten et al. Rheumatologic manifestations of pachydermoperiostosis and preliminary experience with bisphosphonates. J. Rheumatol. 27, 2418\u20132423 (2000)","journal-title":"J. Rheumatol."},{"key":"3804_CR33","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1097\/RHU.0b013e3181df91c6","volume":"16","author":"FV da Costa","year":"2010","unstructured":"F.V. da Costa, S.C. de Magalh\u00e3es Souza Fialho, A.F. Zimmermann, F.S. Neves, G.R. Werner de Castro, I.A. Pereira, Infliximab treatment in pachydermoperiostosis: a rare disease without an effective therapeutic option. J. Clin. Rheumatol. Pr. Rep. Rheum. Musculoskelet. Dis. 16, 183\u2013184 (2010)","journal-title":"J. Clin. Rheumatol. Pr. Rep. Rheum. Musculoskelet. Dis."},{"key":"3804_CR34","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/j.jbspin.2005.11.009","volume":"73","author":"M Younes","year":"2006","unstructured":"M. Younes, M. Touzi, I. B\u00e9jia, S. Zrour-Hassen, N. Amara, M. Ben Hammouda et al. Primary hypertrophic osteoarthropathy with bilateral destructive hip arthritis. Jt. Bone Spine 73, 477\u2013479 (2006)","journal-title":"Jt. Bone Spine"},{"key":"3804_CR35","doi-asserted-by":"crossref","first-page":"2080","DOI":"10.1111\/1756-185X.13736","volume":"22","author":"H Rostom","year":"2019","unstructured":"H. Rostom, M.K. Javaid, A case of primary hypertrophic osteoarthropathy: management considerations. Int. J. Rheum. Dis. 22, 2080\u20132081 (2019)","journal-title":"Int. J. Rheum. Dis."},{"key":"3804_CR36","first-page":"37","volume":"5","author":"SG Bernardo","year":"2012","unstructured":"S.G. Bernardo, J.J. Emer, M.E. Burnett, M. Gordon, Hypertrophic osteoarthropathy presenting as unilateral cellulitis with successful treatment using pamidronate disodium. J. Clin. Aesthet. Dermatol 5, 37\u201346 (2012)","journal-title":"J. Clin. Aesthet. Dermatol"},{"key":"3804_CR37","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1007\/s10067-004-0941-4","volume":"23","author":"H Amital","year":"2004","unstructured":"H. Amital, Y.H. Applbaum, L. Vasiliev, A. Rubinow, Hypertrophic pulmonary osteoarthropathy: control of pain and symptoms with pamidronate. Clin. Rheumatol. 23, 330\u2013332 (2004)","journal-title":"Clin. Rheumatol."},{"key":"3804_CR38","doi-asserted-by":"crossref","first-page":"E65","DOI":"10.1111\/j.1747-0803.2011.00624.x","volume":"8","author":"VA Wijesekera","year":"2013","unstructured":"V.A. Wijesekera, D.J. Radford, Hypertrophic osteoarthropathy in Eisenmenger syndrome. Congenit. Heart Dis. 8, E65\u2013E69 (2013)","journal-title":"Congenit. Heart Dis."},{"key":"3804_CR39","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1378\/chest.121.4.1363","volume":"121","author":"LA Garske","year":"2002","unstructured":"L.A. Garske, S.C. Bell, Pamidronate results in symptom control of hypertrophic pulmonary osteoarthropathy in cystic fibrosis. Chest 121, 1363\u20131364 (2002)","journal-title":"Chest"},{"key":"3804_CR40","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1097\/00001813-200110000-00004","volume":"12","author":"T Suzuma","year":"2001","unstructured":"T. Suzuma, T. Sakurai, G. Yoshimura, T. Umemura, T. Tamaki, T. Yoshimasu et al. Pamidronate-induced remission of pain associated with hypertrophic pulmonary osteoarthropathy in chemoendocrine therapy-refractory inoperable metastatic breast carcinoma. Anticancer Drugs 12, 731\u2013734 (2001)","journal-title":"Anticancer Drugs"},{"key":"3804_CR41","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1136\/bmjspcare-2011-000052","volume":"1","author":"E Birch","year":"2011","unstructured":"E. Birch, D. Jenkins, S. Noble, Treatment of painful hypertrophic osteoarthropathy associated with non-small cell lung cancer with octreotide: a case report and review of the literature. BMJ Support Palliat. Care 1, 189\u2013192 (2011)","journal-title":"BMJ Support Palliat. Care"},{"key":"3804_CR42","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1177\/1049909111421608","volume":"29","author":"M Kilaru","year":"2012","unstructured":"M. Kilaru, C. Vitale, M. Montagnini, Pain management in hypertrophic pulmonary osteoarthropathy: an illustrative case and review. Am. J. Hosp. Palliat. Care 29, 302\u2013307 (2012)","journal-title":"Am. J. Hosp. Palliat. Care"},{"key":"3804_CR43","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.jpainsymman.2015.02.005","volume":"50","author":"M Pourmorteza","year":"2015","unstructured":"M. Pourmorteza, S.J. Baumrucker, A. Al-Sheyyab, M.A.C.P. Da Silva, Hypertrophic pulmonary osteoarthropathy: a rare but treatable condition in palliative medicine. J. Pain. Symptom Manag. 50, 263\u2013267 (2015)","journal-title":"J. Pain. Symptom Manag."},{"key":"3804_CR44","doi-asserted-by":"crossref","first-page":"511","DOI":"10.3357\/AMHP.4848.2017","volume":"88","author":"EM Chumbley","year":"2017","unstructured":"E. M. Chumbley, You\u2019re the Flight Surgeon: a case of bilateral leg pain and swelling in a loadmaster. Aerosp. Med. Hum. Perform. 88, 511\u2013515 (2017)","journal-title":"Aerosp. Med. Hum. Perform"},{"key":"3804_CR45","doi-asserted-by":"crossref","first-page":"99","DOI":"10.5604\/15093492.1032795","volume":"15","author":"M Waszczykowski","year":"2013","unstructured":"M. Waszczykowski, J. Fabi\u015b, T.J. Zwierzchowski, E. Waszczykowska, Evaluation of effectiveness of osteoporosis treatment in patient with pachydermoperiostosis according to densitometric findings. Case study. Ortop. Traumatol. Rehabil. 15, 99\u2013105 (2013)","journal-title":"Ortop. Traumatol. Rehabil."},{"key":"3804_CR46","first-page":"266","volume":"32","author":"J Berdia","year":"2013","unstructured":"J. Berdia, F.F. Tsai, J. Liang, R. Shinder, Pachydermoperiostosis: a rare cause of marked blepharoptosis and floppy eyelid syndrome. Orbit Amst. Neth. 32, 266\u2013269 (2013)","journal-title":"Orbit Amst. Neth."},{"key":"3804_CR47","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1111\/j.1365-4632.2011.05106.x","volume":"51","author":"G Pushpa","year":"2012","unstructured":"G. Pushpa, K. Subashini, N. Murali, V. Rajagopalan, Primary pachydermoperiostosis with hypertrophic gastropathy and a sliding hiatal hernia. Int J. Dermatol 51, 969\u2013972 (2012)","journal-title":"Int J. Dermatol"},{"key":"3804_CR48","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1186\/1752-1947-7-268","volume":"7","author":"Q Zhang","year":"2013","unstructured":"Q. Zhang, M. Shen, B. Yang, K. Yu, A complicated case of pachydermoperiostosis with spondyloarthritides: a case report. J. Med Case Rep. 7, 268 (2013)","journal-title":"J. Med Case Rep."},{"key":"3804_CR49","doi-asserted-by":"crossref","first-page":"bcr2012006759","DOI":"10.1136\/bcr-2012-006759","volume":"2012","author":"N Sonthalia","year":"2012","unstructured":"N. Sonthalia, K. Mukherjee, A. Saha, A. Talukdar, Treatment of hypertrophic osteoarthropathy in the case of pulmonary metastasis secondary-to-nasopharyngeal carcinoma with zoledronic acid: an enlightening experience. BMJ Case Rep. 2012, bcr2012006759 (2012)","journal-title":"BMJ Case Rep."},{"key":"3804_CR50","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.reuma.2011.10.008","volume":"8","author":"WA Sifuentes Giraldo","year":"2012","unstructured":"W.A. Sifuentes Giraldo, M. Ahij\u00f3n Lana, I. Gallego Rivera, F.J. Bachiller Corral, M.L. G\u00e1mir G\u00e1mir, Hypertrophic osteoarthropathy with acro-osteolysis in a patient with primary pulmonary hypertension. Reumatol. Clin. 8, 208\u2013211 (2012)","journal-title":"Reumatol. Clin."},{"key":"3804_CR51","doi-asserted-by":"crossref","first-page":"179","DOI":"10.3816\/CLC.2008.n.027","volume":"9","author":"MM King","year":"2008","unstructured":"M.M. King, D.A. Nelson, Hypertrophic osteoarthropathy effectively treated with zoledronic acid. Clin. Lung Cancer 9, 179\u2013182 (2008)","journal-title":"Clin. Lung Cancer"},{"key":"3804_CR52","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1097\/00008390-200512000-00013","volume":"15","author":"MA Thompson","year":"2005","unstructured":"M.A. Thompson, N.B. Warner, W. J. Hwu, Hypertrophic osteoarthropathy associated with metastatic melanoma. Melanoma Res 15, 559\u2013561 (2005)","journal-title":"Melanoma Res"},{"key":"3804_CR53","doi-asserted-by":"crossref","first-page":"314","DOI":"10.3816\/CLC.2005.n.012","volume":"6","author":"CJ Langer","year":"2005","unstructured":"C.J. Langer, Role of zoledronic acid in the setting of bone metastases from non-small-cell lung cancer. Clin. Lung Cancer 6, 314\u2013316 (2005)","journal-title":"Clin. Lung Cancer"},{"key":"3804_CR54","first-page":"71","volume":"1","author":"I Nahar","year":"2007","unstructured":"I. Nahar, M. Al-Shemmeri, M. Hussain, Secondary hypertrophic osteoarthropathy: new insights on pathogenesis and management. Gulf J. Oncol. 1, 71\u201376 (2007)","journal-title":"Gulf J. Oncol."},{"key":"3804_CR55","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1007\/s11060-016-2186-x","volume":"129","author":"T Nakazawa","year":"2016","unstructured":"T. Nakazawa, M. Nakamura, R. Matsuda, F. Nishimura, Y.S. Park, Y. Motoyama et al. Antitumor effects of minodronate, a third-generation nitrogen-containing bisphosphonate, in synergy with \u03b3\u03b4T cells in human glioblastoma in vitro and in vivo. J. Neurooncol 129, 231\u2013241 (2016)","journal-title":"J. Neurooncol"},{"key":"3804_CR56","doi-asserted-by":"crossref","first-page":"269","DOI":"10.2165\/00063030-200418040-00004","volume":"18","author":"D Santini","year":"2004","unstructured":"D. Santini, M.E. Fratto, B. Vincenzi, A. La Cesa, C. Dianzani, G. Tonini, Bisphosphonate effects in cancer and inflammatory diseases: in vitro and in vivo modulation of cytokine activities. BioDrugs 18, 269\u2013278 (2004)","journal-title":"BioDrugs"},{"key":"3804_CR57","doi-asserted-by":"crossref","first-page":"57932","DOI":"10.18632\/oncotarget.10773","volume":"7","author":"P Jiang","year":"2016","unstructured":"P. Jiang, P. Zhang, R. Mukthavaram, N. Nomura, S.C. Pingle, D. Teng et al. Anti-cancer effects of nitrogen-containing bisphosphonates on human cancer cells. Oncotarget 7, 57932\u201357942 (2016)","journal-title":"Oncotarget"},{"key":"3804_CR58","doi-asserted-by":"crossref","first-page":"2211","DOI":"10.3899\/jrheum.150364","volume":"42","author":"G Giancane","year":"2015","unstructured":"G. Giancane, C.P. Diggle, E.G. Legger, J. Tekstra, B. Prakken, A.B. Brenkman et al. Primary hypertrophic osteoarthropathy: an update on patient features and treatment. J. Rheumatol. 42, 2211\u20132214 (2015)","journal-title":"J. Rheumatol."},{"key":"3804_CR59","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1002\/jbmr.3157","volume":"32","author":"SS Li","year":"2017","unstructured":"S. S. Li, J. W. He, W. Z. Fu, Y. J. Liu, Y. Q. Hu, Z. L. Zhang, Clinical, biochemical, and genetic features of 41 han chinese families with primary hypertrophic osteoarthropathy, and their therapeutic response to etoricoxib: results from a six-month prospective clinical intervention. J. Bone Min. Res J. Am. Soc. Bone Min. Res 32, 1659\u20131666 (2017)","journal-title":"J. Bone Min. Res J. Am. Soc. Bone Min. Res"},{"key":"3804_CR60","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.jdermsci.2017.12.012","volume":"90","author":"P Shakya","year":"2018","unstructured":"P. Shakya, K.N. Pokhrel, L.B. Mlunde, S. Tan, E. Ota, H. Niizeki, Effectiveness of non-steroidal anti-inflammatory drugs among patients with primary hypertrophic osteoarthropathy: a systematic review. J. Dermatol Sci. 90, 21\u201326 (2018)","journal-title":"J. Dermatol Sci."},{"key":"3804_CR61","first-page":"109","volume":"18","author":"L Yuan","year":"2019","unstructured":"L. Yuan, R. X. Liao, Y. Y. Lin, Y. Jiang, O. Wang, M. Li et al. Safety and efficacy of cyclooxygenase-2 inhibition for treatment of primary hypertrophic osteoarthropathy: a single-arm intervention trial. J. Orthop. Transl. 18, 109\u2013118 (2019)","journal-title":"J. Orthop. Transl."}],"container-title":["Endocrine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-024-03804-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12020-024-03804-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-024-03804-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,31]],"date-time":"2024-07-31T08:00:31Z","timestamp":1722412831000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12020-024-03804-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,2]]},"references-count":61,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2024,8]]}},"alternative-id":["3804"],"URL":"https:\/\/doi.org\/10.1007\/s12020-024-03804-5","relation":{},"ISSN":["1559-0100"],"issn-type":[{"value":"1559-0100","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,4,2]]},"assertion":[{"value":"18 December 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 March 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 April 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Patient consent was obtained for the case report.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not obtained as the literature review involved public domain data.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}